SCI时时刷

search
+
The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia
The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia
Improvements made during the last decades in the management of patients with hematologic neoplasia have resulted in increa...
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS registry
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS registry
Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many severe blood diseases. As many pat...
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
Myeloid neoplasms with germline predisposition have been recognized increasingly over the past decade with numerous newly ...
Using real-world evidence in haematology
Using real-world evidence in haematology
Volume 37, Issue 1, March 2024, 101536Author links open overlay panel, , , , , , AbstractMost new drug approvals are based...
Corrigendum to “Designing and conducting a clinical trial in blood and marrow transplantation” [Best Pract Res Clin Haematol 36 (2023) 101471]
Corrigendum to “Designing and conducting a clinical trial in blood and marrow transplantation” [Best Pract Res Clin Haematol 36 (2023) 101471]
Volume 37, Issue 1, March 2024, 101538Author links open overlay panelMichael J. Martens a b, Yan Gao a, Aniko Szabo aShow ...
Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479]
Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479]
Volume 37, Issue 1, March 2024, 101540Author links open overlay panelRuta Brazauskas a, Mary Eapen b, Tao Wang aShow moreP...
Cytogenetics and genomics of acute myeloid leukemia
Cytogenetics and genomics of acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease with distinctive genetic abnormalities. The application of genetic...
Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors
Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors
Childhood and young adult survivors of Hodgkin lymphoma are at an elevated risk of developing breast cancer [[1], [2], [3]...
Progress and Challenges in the Acute Leukemia Field
Progress and Challenges in the Acute Leukemia Field
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
Approaches to comparing safety and efficacy of interventions include analyzing data from randomized controlled trials (RCT...
The international cooperative Gaucher group (ICCG) Gaucher registry
The international cooperative Gaucher group (ICCG) Gaucher registry
Gaucher disease (GD) is a rare, autosomal recessive inborn error of metabolism caused by deficient acid β-glucosidase acti...
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry
The bone marrow failure syndromes (BMFS) are a diverse group of acquired and inherited diseases which may manifest in cyto...
The Best GVHD Prophylaxis: or at least progress towards finding it.
The Best GVHD Prophylaxis: or at least progress towards finding it.
Available online 20 October 2023, 101520Author links open overlay panel, , AbstractOptions for GVHD prophylaxis after allo...
Mechanisms of Resistance to Hypomethylating Agents And BCL-2 inhibitors
Mechanisms of Resistance to Hypomethylating Agents And BCL-2 inhibitors
Available online 20 October 2023, 101521Author links open overlay panel, , AbstractMyeloid malignancies such as myelodyspl...
WHO, What, When, Where, and Why: New Classification Systems for Acute Myeloid Leukemia and Their Impact on Clinical Practice
WHO, What, When, Where, and Why: New Classification Systems for Acute Myeloid Leukemia and Their Impact on Clinical Practice
For those interested in acute myeloid leukemia (AML), 2022 may be remembered as the year of reclassification. In 2022, the...
When to Use Which Molecular Prognostic Scoring System in the Management of Patients with MDS?
When to Use Which Molecular Prognostic Scoring System in the Management of Patients with MDS?
Myelodysplastic syndromes/neoplasms (MDS) are a heterogeneous group of hematopoietic neoplasms characterized by ineffectiv...
Asparaginase Dosing for Obese Patients with Acute Lymphoblastic Leukemia and Factors that Contribute to Outcomes
Asparaginase Dosing for Obese Patients with Acute Lymphoblastic Leukemia and Factors that Contribute to Outcomes
The anti-cancer properties of asparagine depletion were first described in animal models as far back as the 1950s [[1], [2...
Cytogenomics of B-cell non-Hodgkin lymphomas: The “old” meets the “new”
Cytogenomics of B-cell non-Hodgkin lymphomas: The “old” meets the “new”
For the routine diagnosis of haematological neoplasms an integrative approach is used considering the morphology, and the ...
Cardiac surgery for radiation associated heart disease in Hodgkin lymphoma patients
Cardiac surgery for radiation associated heart disease in Hodgkin lymphoma patients
Treatment of Hodgkin's Lymphoma (HL) has now improved to a stage where more than 80% of patients experience 5-year surviva...
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
Classical Hodgkin Lymphoma (cHL) is a B-cell lymphoma with an incidence of approximately 3 cases per 100,000 individuals p...
Cytogenetics and molecular genetics of myelodysplastic neoplasms
Cytogenetics and molecular genetics of myelodysplastic neoplasms
MDS are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more lineage...
Hodgkin lymphoma: Focus on evolving treatment paradigms
Hodgkin lymphoma: Focus on evolving treatment paradigms
Hodgkin lymphoma (HL) is an aggressive lymphoma of B-cell origin that was initially described by British pathologist Thoma...
Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia
Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia
Acute lymphoblastic leukaemia (ALL) occurs in both children and adults. However, the median age at initial diagnosis is 15...
Transplantation and Cellular Therapy in Acute Leukemia
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Describing and analyzing complex disease history in retrospective studies
Haematology covers a great variety of blood-related complex diseases with different causes, therapies, clinical courses an...
Graft versus Leukemia in 2023
Allogeneic hematopoietic stem cell transplantation (HSCT) is the transfer of a hematopoietic and immune system from a heal...
Preface of special edition “Biostatistics in clinical haematology”
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Donor lymphocyte infusion in Acute Myeloid Leukemia
Allogeneic hematopoietic cell transplantation (allo-HCT) has the potential to cure patients with Acute Myeloid Leukemia (A...
The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
One of the consistent features in development of hematopoietic stem cell transplant (HCT) for Acute Lymphoblastic Leukemia...
“The State of the Science” of Childhood, Adolescent and Young Adult Non Hodgkin Lymphoma (NHL)
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
阅读更多
format_indent_increase